Skip to content
WeighLab

Vitara RX vs PepHaūs

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Vitara RX has the higher Cost-Efficiency Index: 87/100 versus 85/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Vitara RX
49 states
PepHaūs
All 50 states

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Vitara RX

PepHaūs

Semaglutide / month
Vitara RX: $99/mo
PepHaūs: $152/mo
Tirzepatide / month
Vitara RX: $149/mo
PepHaūs: $246/mo
Semaglutide / year (modeled)
Vitara RX: $1,188
PepHaūs: $1,824
Tirzepatide / year (modeled)
Vitara RX: $1,788
PepHaūs: $2,952
State availability
Vitara RX: 49 states
PepHaūs: All 50 states
Oral / sublingual option listed
Vitara RX: Not listed
PepHaūs: Not listed
Brand-name access listed
Vitara RX: Not confirmed
PepHaūs: Not confirmed
Provider facts checked
Vitara RX: October 2026
PepHaūs: See full review

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Vitara RX

Value-first shoppers outside Alaska who want one flat price on both molecules at every dose.

Reasons to consider it

  • $99 semaglutide and $149 tirzepatide at every dose, among the lowest combined prices we track
  • Serves 49 states with both molecules priced up front, so the year is easy to model
  • LegitScript-certified at a budget price

What to weigh up

  • Compounded only, with no FDA-approved brand-name or oral/sublingual route
  • Doesn't serve Alaska
  • A homepage banner says plans start at $179.99 a month, which doesn't match the $99 and $149 price cards below it, so check the figure at checkout

PepHaūs

People who want a verified all-50 program with both molecules disclosed and will pay mid-market for the peace of mind.

Reasons to consider it

  • Both molecules disclosed at flat prices with nationwide all-50 access
  • LegitScript-certified pharmacy behind the program
  • Predictable pricing that's straightforward to model for a year

What to weigh up

  • $152/$246 is mid-market — undercut on raw cost by several verified all-50 rivals
  • Compounded only — no brand-name or oral option

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Vitara RXPepHaūs
Normalized Cost/Month
Vitara RX:
94/100
PepHaūs:
80/100
Price Transparency
Vitara RX:
87/100
PepHaūs:
86/100
Nationwide Access
Vitara RX:
88/100
PepHaūs:
96/100
Formulation Options
Vitara RX:
78/100
PepHaūs:
78/100
Clinical Oversight
Vitara RX:
86/100
PepHaūs:
86/100
Contract Flexibility
Vitara RX:
82/100
PepHaūs:
82/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.